Organon OGN
NYSE OGN
$13.75 +0.01 (+0.07%)
At close: Aug 21, 2026 · 4:00 PM EDT

Organon (OGN) Change in Account Payables (2020 - 2026)

Organon (OGN) posted quarterly Change in Account Payables of $74.0 million for Q2 2026, up 85.0% year-over-year from $40.0 million in Q2 2025, and up 131.25% on a QoQ basis from $32.0 million in Q1 2026.

Organon (OGN) Change in Account Payables (2020 - 2026) Analysis & Trends

Organon has reported Change in Account Payables for 7 years, with the latest figure at $74.0 million in Q2 2026.

  • Change in Account Payables for Q2 2026 came in at $74.0 million, up 85.0% year-over-year; the trailing twelve-month figure through Jun 2026 was -$2.0 million (up 99.05% YoY), and the FY2025 annual result was -$217.0 million, down 38.22% from the prior year.
  • Change in Account Payables grew to $74.0 million in Q2 2026, from $32.0 million in the prior quarter.
  • Over five years, Change in Account Payables peaked at $293.0 million in Q2 2024 and troughed at -$349.0 million in Q1 2024.
  • A 5-year average of -$19.0 million and a median of $22.0 million in 2025 frame the typical range for Change in Account Payables.
  • The widest annual swing landed in 2023, when Change in Account Payables soared 168.6%; it then plunged 306.9% in 2025.
  • A 5-year view of Change in Account Payables shows it stood at $86.0 million in 2022, then surged by 168.6% to $231.0 million in 2023, then tumbled by 74.89% to $58.0 million in 2024, then sank by 306.9% to -$120.0 million in 2025, then jumped by 161.67% to $74.0 million in 2026.
  • Per Business Quant data, the three most recent Change in Account Payables figures were $74.0 million in Q2 2026, $32.0 million in Q1 2026, and -$120.0 million in Q4 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Account Payables (Qtr)
1 Johnson & Johnson 652.20 Bn 631.44 Bn 17.26 Bn -
2 AbbVie 469.51 Bn 462.94 Bn 12.70 Bn -
3 Merck 376.81 Bn 369.67 Bn 12.21 Bn -
4 Novartis Ag 303.04 Bn 295.35 Bn 11.24 Bn -
5 Astrazeneca 257.61 Bn 252.71 Bn 12.86 Bn -
6 Amgen 237.37 Bn 223.38 Bn 7.24 Bn -70.00 Mn
7 Gilead Sciences 181.73 Bn 178.55 Bn 6.22 Bn 18.00 Mn
8 Pfizer 159.66 Bn 147.96 Bn 10.94 Bn -
9 Gsk 106.24 Bn 102.07 Bn 8.24 Bn -
10 Organon 3.61 Bn 2.48 Bn 847.00 Mn 74.00 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 74.00 Mn
Jun 30, 2026 74.00 Mn
Mar 31, 2026 32.00 Mn
Mar 31, 2026 32.00 Mn
Dec 31, 2025 -120.00 Mn
Dec 31, 2025 -120.00 Mn
Sep 30, 2025 12.00 Mn
Sep 30, 2025 12.00 Mn
Jun 30, 2025 40.00 Mn
Jun 30, 2025 40.00 Mn
Mar 31, 2025 -149.00 Mn
Mar 31, 2025 -149.00 Mn
Dec 31, 2024 58.00 Mn
Dec 31, 2024 58.00 Mn
Sep 30, 2024 -159.00 Mn
Sep 30, 2024 -159.00 Mn
Jun 30, 2024 293.00 Mn
Jun 30, 2024 293.00 Mn
Mar 31, 2024 -349.00 Mn
Mar 31, 2024 -349.00 Mn